Fig. 9From: CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signalingA working model of circSCAP on inhibiting progression of lung cancer via downregulating SF3A3 protein level and activating p53 signalingBack to article page